Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Federica Novazzi et al.
Summary: With an increase in COVID-19 cases at the end of 2022 in China, some countries have started or expanded testing and genomic surveillance of travelers. Screening results in Italy in late December 2022 showed that 22.7% of flight passengers from two Chinese provinces tested positive for SARS-CoV-2. Whole genome sequencing revealed Omicron variants among the positive samples, consistent with data from China.
Letter
Medicine, General & Internal
Meredith E. Davis-Gardner et al.
Summary: One or two monovalent vaccine boosters resulted in a significant decrease in neutralization activity against omicron subvariants. The BA.5-containing bivalent booster improved neutralizing activity against all omicron subvariants.
NEW ENGLAND JOURNAL OF MEDICINE
(2023)
Letter
Infectious Diseases
Anna Z. Mykytyn et al.
Article
Pharmacology & Pharmacy
Junhyung Cho et al.
Summary: The newly emerged Omicron subvariants, including BQ.1.1, BF.7, BA.5.2, XBB.1, XBB.1.5, and BN.1.9, have become prevalent global strains (>5% global prevalence) from November 2022 to February 2023. These subvariants are resistant to several therapeutic antibodies and the antiviral efficacy of current drugs needs to be evaluated. However, the study showed that current antivirals still retain their effectiveness against the newly emerged Omicron subvariants.
ANTIVIRAL RESEARCH
(2023)
Review
Microbiology
MacGregor Cox et al.
Summary: Monoclonal antibodies (mAbs) are an important treatment option for severe COVID-19, but the emergence of new SARS-CoV-2 variants has led to evasion of mAb-induced protection. Spike protein amino acid substitutions, both at epitope and non-epitope positions, play a role in resistance to mAb neutralization. Understanding the dynamics of viral evasion can inform surveillance and the development of novel mAb therapies.
NATURE REVIEWS MICROBIOLOGY
(2023)
Article
Environmental Sciences
G. La Rosa et al.
Summary: This study provides new insights into the occurrence and spread of SARS-CoV-2 Variants of Concern (VOCs) and Variants of Interest (VOIs) in Italy in October and November 2022, using urban wastewater testing. The results suggest an increased dominance of the BQ.1/BQ.1.1 lineage in late 2022, and the detection of previously unseen variants in Italian wastewater.
SCIENCE OF THE TOTAL ENVIRONMENT
(2023)
Article
Multidisciplinary Sciences
Delphine Planas et al.
Summary: Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages have led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6, and BQ.1.1. These subvariants carry additional mutations in the spike protein, potentially increasing transmissibility and evading immune responses. The study found that the efficacy of monoclonal antibodies and serum from vaccinated individuals against these subvariants varies.
NATURE COMMUNICATIONS
(2023)
Article
Multidisciplinary Sciences
Jumpei Ito et al.
Summary: This study evaluates the importance of 5 mutations and characterizes the virological properties of variant BQ.1.1. Younger Omicron lineages are found to be more likely to acquire these mutations, which increase viral fitness. BQ.1.1 variant evades BA.2 and BA.5 infections more efficiently and exhibits lower pathogenicity in hamsters compared to BA.5. This study provides insights into the convergent evolution of known Omicron lineages as of 2022.
NATURE COMMUNICATIONS
(2023)
Letter
Cell Biology
Ryan Varghese et al.
Article
Public, Environmental & Occupational Health
Kevin C. Ma et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2023)
Article
Biochemistry & Molecular Biology
Qian Wang et al.
Summary: The BQ and XBB subvariants of SARS-CoV-2 Omicron, with additional spike mutations, are rapidly expanding and have altered antibody evasion properties. Neutralization of BQ.1, BQ.1.1, XBB, and XBB.1 by vaccinated individuals and infected persons' sera was significantly impaired, including those boosted with a WA1/BA.5 bivalent mRNA vaccine. The titers against BQ and XBB subvariants were much lower than observed before, indicating that these subvariants pose a serious threat to current COVID-19 vaccines and render all authorized antibodies inactive.
News Item
Medicine, General & Internal
[Anonymous]
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE
(2022)
Letter
Critical Care Medicine
Antoine Vieillard-Baron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
(2022)
Article
Virology
Slim Fourati et al.
Summary: This study aimed to investigate the relationship between SARS-CoV-2 variants and clinical outcomes. The findings showed that the alpha variant did not increase the risk of mortality compared to other variants. Additionally, there was no association between specific variants or mutations and day-28 mortality.
Article
Biochemistry & Molecular Biology
Izumi Kimura et al.
Summary: After the global spread of SARS-CoV-2 Omicron BA.2, several BA.2 subvariants, including BA.2.9.1, BA.2.11, BA.2.12.1, BA.4, and BA.5, emerged in multiple countries. Statistical analysis showed that these BA.2 subvariants have higher effective reproduction numbers than the original BA.2. Neutralization experiments revealed that the immunity induced by BA.1/2 infections is less effective against BA.4/5. Cell culture experiments demonstrated that BA.2.12.1 and BA.4/5 replicate more efficiently in human alveolar epithelial cells than BA.2, with BA.4/5 being more fusogenic. The study also provided the structure of the BA.4/5 spike receptor-binding domain and investigated the substitutions in the BA.4/5 spike that play a role in ACE2 binding and immune evasion. Additionally, experiments using hamsters suggested that BA.4/5 is more pathogenic than BA.2. The multiscale investigations suggest that the risk of BA.2 subvariants, particularly BA.4/5, to global health is greater than that of the original BA.2.
Article
Microbiology
Akatsuki Saito et al.
Summary: The SARS-CoV-2 Omicron BA.2.75 variant, emerged in May 2022, demonstrates distinct virological properties compared to its ancestors BA.2 and BA.5. It exhibits higher effective reproduction number and sensitivity to antibodies, as well as greater affinity for the human receptor ACE2 and pathogenicity in hamsters.
CELL HOST & MICROBE
(2022)
Article
Multidisciplinary Sciences
Nicolas de Prost et al.
Summary: In this prospective study, it was found that the clinical phenotype of patients infected with the Omicron variant differs from those infected with the Delta variant. Immunocompromised patients infected with the Omicron variant have a significantly higher mortality rate compared to non-immunocompromised patients. However, no association was observed between specific sublineages or viral genome polymorphisms/mutational profiles of the Omicron variant and mortality.
NATURE COMMUNICATIONS
(2022)
Article
Multidisciplinary Sciences
Rahul C. Bhoyar et al.
Summary: The study utilized the COVIDSeq protocol for high-throughput detection of SARS-CoV-2, showing high concordance with RT-PCR and potential as a confirmatory test. It also provided insights into the genetic epidemiology of SARS-CoV-2 samples, identifying several new variants.
Article
Critical Care Medicine
Matthieu Schmidt et al.
Summary: Among more than 4000 critically ill patients with COVID-19 admitted to our ICUs, 90-day mortality was 31% and decreased from 42 to 25% over the study period. Mortality was higher in older, diabetic, obese and severe ARDS patients.
INTENSIVE CARE MEDICINE
(2021)
Article
Microbiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY
(2020)
Article
Infectious Diseases
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Multidisciplinary Sciences
Elizabeth J. Williamson et al.
Review
Infectious Diseases
Philipp Koehler et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Critical Care Medicine
Marc Leone et al.
ANNALS OF INTENSIVE CARE
(2018)
Article
Medicine, General & Internal
K Rockwood et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL
(2005)
